Enalapril

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf gptkb:drug
ACE inhibitor
gptkbp:administeredBy gptkb:tablet
oral solution
gptkbp:approvalYear 1984
gptkbp:ATCCode C09AA02
gptkbp:bioavailability 60%
gptkbp:brand gptkb:Renitec
gptkb:Vasotec
gptkbp:CASNumber 75847-73-3
gptkbp:category prodrug
antihypertensive agent
carboxylate ester
dicarboxylic acid derivative
gptkbp:cause dizziness
rash
renal impairment
elevated creatinine
gptkbp:chemicalFormula C20H28N2O5
gptkbp:contraindication pregnancy
history of angioedema
gptkbp:discoveredBy gptkb:Merck_&_Co.
gptkbp:discoveredIn gptkb:United_States
gptkbp:eliminationHalfLife 11 hours (enalaprilat)
gptkbp:essentialMedicine gptkb:WHO_Model_List_of_Essential_Medicines
gptkbp:excretion gptkb:kidney
gptkbp:firstSynthesized 1978
gptkbp:genericAvailable yes
https://www.w3.org/2000/01/rdf-schema#label Enalapril
gptkbp:interactsWith gptkb:NSAIDs
gptkb:aliskiren
lithium
diuretics
potassium-sparing diuretics
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits angiotensin-converting enzyme
gptkbp:metabolism liver
gptkbp:molecularWeight 376.447 g/mol
gptkbp:notRecommendedFor pregnant women
patients with bilateral renal artery stenosis
gptkbp:patentExpired yes
gptkbp:pregnancyCategory D (US)
gptkbp:prescribes adults
children (in some cases)
gptkbp:prodrugOf gptkb:enalaprilat
gptkbp:proteinBinding 50–60%
gptkbp:routeOfAdministration oral
gptkbp:sideEffect cough
hypotension
hyperkalemia
angioedema
gptkbp:usedFor heart failure
hypertension
left ventricular dysfunction
gptkbp:bfsParent gptkb:Zentiva
gptkbp:bfsLayer 7